3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
40
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
18
Rectal Neoplasms
14
Lung Neoplasms
13
Stomach Neoplasms
12
Esophageal Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
9
Esophageal Squamous Cell Carcinoma
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
8
Neoplasm Metastasis
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Ovarian Neoplasms
7
Neoplasms
6
Head and Neck Neoplasms
6
Urinary Bladder Neoplasms
5
Osteosarcoma
5
Liver Neoplasms
5
Kidney Neoplasms
4
Inflammatory Breast Neoplasms
4
Fallopian Tube Neoplasms
4
Carcinoma, Renal Cell
4
Breast Neoplasms, Male
4
Turcot syndrome
3
Multiple Myeloma
3
Locally Advanced Rectal Cancer
3
Interventions
Carboplatin
4
Trastuzumab
3
Cyclophosphamide
3
Paclitaxel
2
Letrozole
2
Fulvestrant
2
Docetaxel
2
repotrectinib
1
proto-oncogene protein c-fes-fps
1
palbociclib
1
neratinib
1
entrectinib
1
Vorinostat
1
Vinorelbine
1
Thiotepa
1
Taxes
1
Tamoxifen
1
Sugars
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Naltrexone
1
Melphalan
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
High-Energy Shock Waves
1
Goserelin
1
Fluorine-18
1
Epirubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Lobular
×
Neoadjuvant Therapy
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled